Developing differentiated medicines

for devastating diseases including intractable cancers, lymphatic and GI diseases, CNS disorders and inflammatory and immunological diseases

Exploring the Brain Immune Gut (BIG) Axis

Relationships with 8 major pharma companies
or their investment arms

 

23 product candidates

14 are clinical stage

1 FDA cleared product

Team of industry leaders and experts

Publications
Publications -2018-03-23
Internal Pipeline
PureTech's Lymphatic Leap
Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
Vedanta
Science: The Gut’s Clostridium Cocktail
Publications
2020-03-19
Frontiers: Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies
Press releases
2020-03-11
PureTech Affiliate Gelesis Named One of the World’s Most Innovative Companies for 2020 by Fast Company

Continue

Press releases
2020-03-10
Notice of Results

 

Continue